0001144204-17-008458
venBio Select Advisor LLC (CIK 0001633313)
Total Value: $495,012
Total Holdings: 44
QuarterFilling ID
Q4 250002002654-26-000001
Q3 250002002654-25-000006
Q2 250002002654-25-000004
Q1 250002002654-25-000003
Q4 240002002654-25-000001
Q3 240002002654-24-000005
Q2 240002002654-24-000004
Q1 240002002654-24-000002
Q4 230002002654-24-000001
Q3 230002002654-23-000008
Q2 230002002654-23-000007
Q1 230002002654-23-000006
Q4 220002002654-23-000005
Q3 220002002654-23-000004
Q2 220002002654-23-000003
Q1 220002002654-23-000002
Q4 210002002654-23-000001
Compare Quarter:
NameTitleCUSIPTickerValueSharesShare PriceInvestment% of Portfolio
ACADIA PHARMACEUTICALS INCCommon004225108ACAD$43,2831,686,460SOLE
IMMUNOMEDICS INCCommon452907108IMMU$34,0199,564,140SOLE
BIOMARIN PHARMACEUTICAL INCCommon09061G101BMRN$33,136400,000SOLE
LION BIOTECHNOLOGIES INCCommon53619R102$31,4184,520,643SOLE
TESARO INCCommon881569107T8S$31,159231,700SOLE
SAREPTA THERAPEUTICS INCCommon803607100SRPT$28,3281,160,300SOLE
NEURODERM LTDCommonM74231107$23,4501,056,303SOLE
DERMIRA INCCommon24983L104DERMEUR$23,224765,709SOLE
AERIE PHARMACEUTICALS INCCommon00771V108AERIEUR$23,089610,000SOLE
NEUROCRINE BIOSCIENCES INCCommon64125C109$20,937541,000SOLE
ALEXION PHARMACEUTICALS INCCommon015351109ALXN$20,800170,000SOLE
AMICUS THERAPEUTICS INCCommon03152W109FOLD$19,9674,017,577SOLE
BRISTOL MYERS SQUIBB CO.Common110122108BMY$16,655285,000SOLE
SEATTLE GENETICS INCCommon812578102SGENEUR$15,595295,533SOLE
AGENUS INCCommon00847G705AGENEUR$15,4774,750,430SOLE
GLOBAL BLOOD THERAPEUTICS INCCommon37890U108GBTUSD$14,390995,838SOLE
ASCENDIS PHARMASponsored ADR04351P101ASND$11,035545,203SOLE
TELIGENT INCCommon87960W104$10,9971,663,619SOLE
BIOCRYST PHARMACEUTICALS INCCommon09058V103BCRX$10,3271,631,502SOLE
AKEBIA THERAPEUTICS INCCommon00972D105AKBA$8,656831,515SOLE
MIRATI THERAPEUTICS INCCommon60468T105MRTXEUR$7,1641,508,201SOLE
SORRENTO THERAPEUTICS INCCommon83587F202SRNE$7,1351,456,056SOLE
VERACYTE INCCommon92337F107VCYT$7,020906,999SOLE
VANDA PHARMACEUTICALS INCCommon921659108VNDA$6,084381,466SOLE
ALIMERA SCIENCES INCCommon016259103ALIMEUR$4,3574,034,488SOLE
CASCADIAN THERAPEUTICS INCCommon14740B606$3,971921,248SOLE
XENCOR INCCommon98401F105XNCR$3,290125,000SOLE
ASSEMBLY BIOSCIENCES INCCommon045396108$3,284270,289SOLE
FORTRESS BIOTECH INCCommon34960Q109$3,2411,200,342SOLE
CORVUS PHARMACEUTICALS INCCommon221015100CRVS$3,098216,619SOLE
ONCOBIOLOGICS INCCommon68235M105$2,057683,531SOLE
CELLECTIS – ADRSponsored ADR15117K103CLLS$1,64697,096SOLE
PERNIX THERAPEUTICS HOLDINGS INCConvertible Debt71426VAK4PTX 4.25 04/01/21$1,4796,000,000SOLE
ARRAY BIOPHARMA INCCommon04269X105ARRYEUR$1,406160,000SOLE
TRILLIUM THERAPEUTICS INCCommon89620X506TREUR$1,285227,399SOLE
CATALYST PHARMACEUTICALS INCCommon14888U101CPRX$1,1981,141,149SOLE
BIODELIVERY SCIENCES INTL INCCommon09060J106BDSIUSD$1,127644,176SOLE
ONCOBIOLOGICS INC – WARRANT BWarrant68235M121$184233,333SOLE
ONCOBIOLOGICS INC – WARRANT AWarrant68235M113$44233,333SOLE